Analystreport

Fresenius Medical Care AG & Co. (NYSE: FMS) was upgraded by analysts at UBS Group AG to a "buy" rating. They now have a $82.00 price target on the stock.

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)  (FMS) 
Last fresenius medical care ag american depositary shares (each representing 1/2 of an ordinary share) earnings: 7/31 04:03 pm Check Earnings Report